Clinical Trials Directory

Trials / Completed

CompletedNCT06396832

Comparing Post-Surgical Symptoms: Gastric Sleeve With and Without Omentopexy "Comparing Post-Surgical Symptoms: Gastric Sleeve With and Without Omentopexy" Comparison of Postoperative Symptoms: Gastric Sleeve With and Without Omentopexy.

POST-SURGICAL SYMPTOMS IN PATIENTS UNDERGOING GASTRIC SLEEVE SURGERY: OMENTOPEXY VS. NO OMENTOPEXY

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
Instituto Mexicano del Seguro Social · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Metabolic surgery has proven to be an effective treatment for obesity, with laparoscopic sleeve gastrectomy being the most popular procedure. Omentopexy (OP) is proposed as a strategy to reduce associated complications. Objective was to determine the effectiveness of omentopexy in controlling post-surgical symptoms and to measure the need for re-intervention, leakage, bleeding, and mortality in patients undergoing laparoscopic sleeve gastrectomy.

Detailed description

Patients who underwent laparoscopic sleeve gastrectomy (LSG). Of these patients, 53 received LSG with omentopexy (OP) and 52 underwent LSG without omentopexy (NO OP) between 2022 and 2023. Each group was attended by a different surgeon. The analysis focused on data concerning gastrointestinal symptoms recorded 24 hours postoperatively, as well as documented cases of bleeding, leakage, re-operation, and mortality during the hospitalization period

Conditions

Timeline

Start date
2022-05-01
Primary completion
2023-02-01
Completion
2024-04-01
First posted
2024-05-02
Last updated
2024-05-02

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT06396832. Inclusion in this directory is not an endorsement.